WPD Pharmaceuticals Inc.
WBIO
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 34.10K | 57.50K | 69.20K | 44.60K | 46.40K |
| Depreciation & Amortization | 2.00K | 2.00K | 2.00K | 2.10K | 2.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 36.10K | 59.50K | 71.20K | 46.60K | 49.10K |
| Operating Income | -36.10K | -59.50K | -71.20K | -46.60K | -49.10K |
| Income Before Tax | 34.80K | -13.90K | -116.90K | 90.00K | -64.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.80K | -13.90K | -116.90K | 90.00K | -64.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.80K | -13.90K | -116.90K | 90.00K | -64.00K |
| EBIT | -36.10K | -59.50K | -71.20K | -46.60K | -49.10K |
| EBITDA | -34.10K | -57.50K | -69.20K | -46.60K | -48.20K |
| EPS Basic | 0.01 | 0.00 | -0.03 | 0.02 | -0.01 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | 0.01 | 0.00 | -0.03 | 0.02 | -0.01 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 4.63M | 4.55M | 4.54M | 4.54M | 4.54M |
| Average Diluted Shares Outstanding | 4.63M | 4.55M | 4.54M | 4.54M | 4.54M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
